Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
NHS TAYSIDE NINEWELLS HOSPITAL & MEDICAL SCHOOL DEPARTMENT OF DERMATOLOGY - PHOTOBIOLOGY UNIT HOME PHOTOTHERAPY EQUIPMENT (HoPE) ULTRAVIOLET B (UVB) TREATMENT PROTOCOL Determine MED (minimal erythema dose) with readings at 24 hours, +/- 6 hours. If the patient’s back is too extensively involved (active/flared) to perform the MED test, the starting dose should be according to skin type (see Photonet skin type protocol) or Doctor’s instructions. If there is no MED reading, use 70% of the maximum MED test dose or seek medical advice. Initial irradiation dose: 70% of MED. UVB treatment will be given every alternate day, with 48-hour minimum interval between treatments. The patient will have successfully completed the training programme, which includes 1 supervised treatment in the Photobiology Unit. For most patients, 2 days of training is adequate, but, if felt necessary, the Phototherapy Nurse will advise a longer training programme. Day 1 (~1½ hrs): completion of nursing documentation and MED test Day 2 (~1 hour): demonstration of equipment and 1st supervised treatment The Phototherapy Nurse will contact the patient every 2 weeks. The patient will also be reviewed midway through their treatment course (after approximately 12 treatments). Further hospital assessments may be required. Exposure time, non-administration of UVB and adverse effects will be documented by the patient on the Treatment Recording Sheet. The Home Phototherapy Equipment must be warmed-up for 4 minutes prior to each treatment. Leave the room during this period. Ensure that nobody enters the room during treatment and warm-up periods. The supplied protective goggles and face shield must be worn at all times unless otherwise specified. Never expose eyes to the lamps. Contact details: In the event of erythema or discomfort, the patient should contact the nursing staff (see below) for advice before administering the next treatment: Ninewells Hospital, Dundee Monday-Friday Saturday Telephone: Photobiology Unit 7.30 am-6.30 pm 8.30 am-12.30 pm 01382 632264 1 Following a painful erythema, outwith the clinic opening hours, the patient should contact: Ward 24, Ninewells Hospital After 6.30 pm and weekends Telephone: Dermatology Ward 01382 633824 Adverse effects: No erythema – give 20% dose increments. Please note for patients with urticaria and atopic eczema 10% increments to be given from start of treatment. Grade 1 (mild) – barely perceptible and resolves within 48 hours. Repeat previous dose then administer 10% dose increments thereafter. Grade 2 (moderate) – well defined erythema, possibly causing slight manageable discomfort. Postpone one treatment then repeat previous dose if completely settled.,Administer 10% dose increments thereafter. Grade 3 (severe) – well defined symptomatic/painful erythema. Do not administer treatment. The patient should be reviewed by a Doctor when possible. When erythema has completely settled, treat with 50% of the previous dose then 10% dose increments thereafter. Grade 4 (very severe) – painful erythema usually with bullae. No treatment and urgent/immediate review by Doctor. In patients with pigmented skin, erythema and oedema may not always be seen; the patient may complain of heat and skin tightness instead. If a patient develops facial erythema or unacceptable facial pigmentation, a protective face shield or sunscreen (such as SPF 50) should be considered, and if started used for each treatment. If a patient develops itch, encourage use of emollient. If itch persists, review by Doctor. If a patient develops Polymorphic Light Eruption (PLE), encourage use of emollients and prescribed topical steroids or seek medical advice. Postpone treatment if troublesome and reduce to 10% dose increments. Discharge – the patient will be reviewed and discharge planned accordingly. If the patient is receiving UVB phototherapy for desensitisation: o Treatment may be given three times weekly or daily o Exposed sites only should be treated unless otherwise stated by the Doctor o Topical steroid should be applied immediately post treatment if prescribed o 15 treatments unless otherwise specified 2 If a patient misses/cancels treatment(s), they should be advised of the following: 1-2 treatments: repeat previous treatment time 3 treatments: administer penultimate treatment time 4-10 treatments: the patient must contact the Phototherapy Unit for advice (give 50% of last treatment dose) More than 3 weeks missed due to, e.g. holiday or illness repeat MED or consult starting dose Operation of the equipment – see ‘Administration of Treatment’. Only nursing staff trained to operate the Home Phototherapy Equipment should administer treatment. Home_UVB_protocol/SusanYule/190813 Review Aug 2014 3